NCT02041754View on ClinicalTrials.gov

Safety and Efficacy of IQP-AK-102 in Reducing Appetite

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Weight LossAppetite Modulation (Focus of Study)

Interventions

DEVICE

IQP-AK-102

DEVICE

Placebo

Trial Locations (1)

10369

Udo Bongartz, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InQpharm Group

INDUSTRY